ADIPOQ and Insulin resistance: Migrenne et al. showed that rimonabant failed to improve insulin sensitivity in adiponectin-deficient mice, suggesting that CB1-mediated inhibition of adiponectin release might be an underlying mechanism for eCBs to cause insulin resistance [214].